| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 7.58e-11 | 145 | 33 | 8 | GO:0004713 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.03e-10 | 19 | 33 | 5 | GO:0005003 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 8.33e-09 | 15 | 33 | 4 | GO:0005005 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 6.91e-08 | 65 | 33 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.68e-07 | 85 | 33 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.16e-06 | 13 | 33 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | protein kinase activity | 4.53e-06 | 600 | 33 | 8 | GO:0004672 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 1.49e-05 | 938 | 33 | 9 | GO:0016772 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 1.53e-05 | 709 | 33 | 8 | GO:0016773 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.63e-05 | 93 | 33 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | ephrin receptor binding | 1.97e-05 | 32 | 33 | 3 | GO:0046875 | |
| GeneOntologyMolecularFunction | kinase activity | 2.63e-05 | 764 | 33 | 8 | GO:0016301 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 5.95e-05 | 46 | 33 | 3 | GO:0004715 | |
| GeneOntologyMolecularFunction | phospholipase activator activity | 6.56e-04 | 23 | 33 | 2 | GO:0016004 | |
| GeneOntologyMolecularFunction | lipase activator activity | 9.06e-04 | 27 | 33 | 2 | GO:0060229 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.01e-03 | 120 | 33 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | phospholipase binding | 1.27e-03 | 32 | 33 | 2 | GO:0043274 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 1.31e-03 | 1353 | 33 | 8 | GO:0004888 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 1.35e-03 | 33 | 33 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.83e-03 | 599 | 33 | 5 | GO:0050839 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 2.83e-03 | 172 | 33 | 3 | GO:0044325 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 2.88e-03 | 173 | 33 | 3 | GO:0070851 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.59e-03 | 187 | 33 | 3 | GO:0016922 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 2.21e-14 | 54 | 34 | 8 | GO:0048013 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 2.18e-07 | 747 | 34 | 10 | GO:0007169 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 1.82e-06 | 1186 | 34 | 11 | GO:0007167 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response to antigenic stimulus | 3.00e-06 | 61 | 34 | 4 | GO:0002861 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 8.09e-06 | 24 | 34 | 3 | GO:0031290 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 9.18e-06 | 25 | 34 | 3 | GO:0002433 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway involved in phagocytosis | 9.18e-06 | 25 | 34 | 3 | GO:0038096 | |
| GeneOntologyBiologicalProcess | cellular response to platelet-derived growth factor stimulus | 1.30e-05 | 28 | 34 | 3 | GO:0036120 | |
| GeneOntologyBiologicalProcess | regulation of endopeptidase activity | 1.53e-05 | 332 | 34 | 6 | GO:0052548 | |
| GeneOntologyBiologicalProcess | branching involved in mammary gland duct morphogenesis | 1.61e-05 | 30 | 34 | 3 | GO:0060444 | |
| GeneOntologyBiologicalProcess | response to platelet-derived growth factor | 1.78e-05 | 31 | 34 | 3 | GO:0036119 | |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 2.42e-05 | 103 | 34 | 4 | GO:0002437 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated stimulatory signaling pathway | 2.58e-05 | 35 | 34 | 3 | GO:0002431 | |
| GeneOntologyBiologicalProcess | hindbrain tangential cell migration | 2.63e-05 | 5 | 34 | 2 | GO:0021934 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response to antigenic stimulus | 3.06e-05 | 37 | 34 | 3 | GO:0002862 | |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway | 3.49e-05 | 113 | 34 | 4 | GO:2001237 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway | 3.59e-05 | 39 | 34 | 3 | GO:0038094 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 3.74e-05 | 115 | 34 | 4 | GO:0097061 | |
| GeneOntologyBiologicalProcess | negative regulation of dendritic spine maintenance | 3.94e-05 | 6 | 34 | 2 | GO:1902951 | |
| GeneOntologyBiologicalProcess | optic nerve morphogenesis | 3.94e-05 | 6 | 34 | 2 | GO:0021631 | |
| GeneOntologyBiologicalProcess | regulation of cysteine-type endopeptidase activity | 4.15e-05 | 238 | 34 | 5 | GO:2000116 | |
| GeneOntologyBiologicalProcess | regulation of peptidase activity | 4.73e-05 | 406 | 34 | 6 | GO:0052547 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 4.83e-05 | 43 | 34 | 3 | GO:0062149 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 5.51e-05 | 127 | 34 | 4 | GO:0106027 | |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 5.54e-05 | 45 | 34 | 3 | GO:0060603 | |
| GeneOntologyBiologicalProcess | T cell costimulation | 8.07e-05 | 51 | 34 | 3 | GO:0031295 | |
| GeneOntologyBiologicalProcess | lymphocyte costimulation | 9.06e-05 | 53 | 34 | 3 | GO:0031294 | |
| GeneOntologyBiologicalProcess | axon guidance | 9.74e-05 | 285 | 34 | 5 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 9.91e-05 | 286 | 34 | 5 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 1.03e-04 | 927 | 34 | 8 | GO:0030155 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | 1.22e-04 | 1226 | 34 | 9 | GO:0042325 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.42e-04 | 309 | 34 | 5 | GO:1901888 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 1.45e-04 | 62 | 34 | 3 | GO:0038093 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 1.51e-04 | 313 | 34 | 5 | GO:0099173 | |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 1.67e-04 | 65 | 34 | 3 | GO:0060443 | |
| GeneOntologyBiologicalProcess | regulation of proteolysis | 1.83e-04 | 748 | 34 | 7 | GO:0030162 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 1.85e-04 | 327 | 34 | 5 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 1.91e-04 | 329 | 34 | 5 | GO:0018212 | |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway | 2.17e-04 | 181 | 34 | 4 | GO:2001236 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 2.35e-04 | 185 | 34 | 4 | GO:0099175 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 2.37e-04 | 780 | 34 | 7 | GO:0042327 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | 3.10e-04 | 815 | 34 | 7 | GO:0043408 | |
| GeneOntologyBiologicalProcess | cellular response to hydrogen peroxide | 3.32e-04 | 82 | 34 | 3 | GO:0070301 | |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 3.56e-04 | 84 | 34 | 3 | GO:0061180 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | 3.70e-04 | 1421 | 34 | 9 | GO:0019220 | |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | 3.74e-04 | 1423 | 34 | 9 | GO:0051174 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 3.93e-04 | 385 | 34 | 5 | GO:0070372 | |
| GeneOntologyBiologicalProcess | negative regulation of protein ubiquitination | 3.95e-04 | 87 | 34 | 3 | GO:0031397 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 3.95e-04 | 87 | 34 | 3 | GO:0033143 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine maintenance | 3.97e-04 | 18 | 34 | 2 | GO:1902950 | |
| GeneOntologyBiologicalProcess | negative regulation of ubiquitin-protein transferase activity | 3.97e-04 | 18 | 34 | 2 | GO:0051444 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 4.03e-04 | 387 | 34 | 5 | GO:0050807 | |
| GeneOntologyBiologicalProcess | brain development | 4.26e-04 | 859 | 34 | 7 | GO:0007420 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | 4.41e-04 | 864 | 34 | 7 | GO:0051129 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 4.42e-04 | 395 | 34 | 5 | GO:0050803 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | 4.86e-04 | 878 | 34 | 7 | GO:0051336 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | 4.89e-04 | 879 | 34 | 7 | GO:0045937 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | 4.89e-04 | 879 | 34 | 7 | GO:0010562 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 5.20e-04 | 228 | 34 | 4 | GO:0046777 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 5.64e-04 | 233 | 34 | 4 | GO:0031345 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 5.72e-04 | 418 | 34 | 5 | GO:0070371 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 5.79e-04 | 1194 | 34 | 8 | GO:0000902 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification by small protein conjugation or removal | 5.93e-04 | 100 | 34 | 3 | GO:1903321 | |
| GeneOntologyBiologicalProcess | optic nerve development | 5.97e-04 | 22 | 34 | 2 | GO:0021554 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | 6.01e-04 | 237 | 34 | 4 | GO:1905475 | |
| GeneOntologyBiologicalProcess | head development | 6.38e-04 | 919 | 34 | 7 | GO:0060322 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 6.53e-04 | 23 | 34 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cell migration in hindbrain | 6.53e-04 | 23 | 34 | 2 | GO:0021535 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 6.53e-04 | 23 | 34 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 6.53e-04 | 23 | 34 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | negative regulation of post-translational protein modification | 6.65e-04 | 104 | 34 | 3 | GO:1901874 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 6.84e-04 | 105 | 34 | 3 | GO:0019233 | |
| GeneOntologyBiologicalProcess | MAPK cascade | 6.84e-04 | 930 | 34 | 7 | GO:0000165 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 7.45e-04 | 251 | 34 | 4 | GO:2000241 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 8.26e-04 | 258 | 34 | 4 | GO:0001763 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in nucleus | 8.36e-04 | 26 | 34 | 2 | GO:0051457 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of pain | 8.36e-04 | 26 | 34 | 2 | GO:0050966 | |
| GeneOntologyBiologicalProcess | extrinsic apoptotic signaling pathway | 8.38e-04 | 259 | 34 | 4 | GO:0097191 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to nucleus | 8.68e-04 | 114 | 34 | 3 | GO:1900182 | |
| GeneOntologyBiologicalProcess | cell junction organization | 8.99e-04 | 974 | 34 | 7 | GO:0034330 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | 9.10e-04 | 976 | 34 | 7 | GO:0018193 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 9.60e-04 | 118 | 34 | 3 | GO:2000243 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 9.64e-04 | 269 | 34 | 4 | GO:0002064 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-tyrosine phosphorylation | 1.00e-03 | 272 | 34 | 4 | GO:0050730 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 1.02e-03 | 475 | 34 | 5 | GO:0140694 | |
| GeneOntologyBiologicalProcess | negative regulation of transferase activity | 1.02e-03 | 273 | 34 | 4 | GO:0051348 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.03e-03 | 121 | 34 | 3 | GO:0051899 | |
| GeneOntologyBiologicalProcess | negative regulation of reactive oxygen species biosynthetic process | 1.04e-03 | 29 | 34 | 2 | GO:1903427 | |
| GeneOntologyBiologicalProcess | skeletal muscle cell proliferation | 1.04e-03 | 29 | 34 | 2 | GO:0014856 | |
| GeneOntologyBiologicalProcess | dendritic spine maintenance | 1.11e-03 | 30 | 34 | 2 | GO:0097062 | |
| GeneOntologyBiologicalProcess | circulatory system process | 1.13e-03 | 733 | 34 | 6 | GO:0003013 | |
| GeneOntologyBiologicalProcess | response to hydrogen peroxide | 1.16e-03 | 126 | 34 | 3 | GO:0042542 | |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway | 1.19e-03 | 127 | 34 | 3 | GO:2001243 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic signaling pathway | 1.21e-03 | 286 | 34 | 4 | GO:2001234 | |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 1.21e-03 | 128 | 34 | 3 | GO:0007265 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to plasma membrane | 1.21e-03 | 128 | 34 | 3 | GO:1903076 | |
| GeneOntologyBiologicalProcess | central nervous system projection neuron axonogenesis | 1.27e-03 | 32 | 34 | 2 | GO:0021952 | |
| GeneOntologyBiologicalProcess | cranial nerve morphogenesis | 1.27e-03 | 32 | 34 | 2 | GO:0021602 | |
| GeneOntologyBiologicalProcess | skeletal muscle adaptation | 1.27e-03 | 32 | 34 | 2 | GO:0043501 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 1.27e-03 | 130 | 34 | 3 | GO:1901655 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 2.02e-06 | 56 | 34 | 4 | GO:0099091 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 3.87e-05 | 817 | 34 | 8 | GO:0098978 | |
| GeneOntologyCellularComponent | dendrite | 5.47e-05 | 858 | 34 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 5.56e-05 | 860 | 34 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | axon | 7.14e-05 | 891 | 34 | 8 | GO:0030424 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.11e-04 | 1228 | 34 | 9 | GO:0036477 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.43e-04 | 503 | 34 | 6 | GO:0099572 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 1.75e-04 | 67 | 34 | 3 | GO:0098686 | |
| GeneOntologyCellularComponent | membrane raft | 2.79e-04 | 362 | 34 | 5 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 2.86e-04 | 364 | 34 | 5 | GO:0098857 | |
| GeneOntologyCellularComponent | cell body | 6.28e-04 | 929 | 34 | 7 | GO:0044297 | |
| GeneOntologyCellularComponent | cell-substrate junction | 7.00e-04 | 443 | 34 | 5 | GO:0030055 | |
| GeneOntologyCellularComponent | anchoring junction | 8.41e-04 | 976 | 34 | 7 | GO:0070161 | |
| GeneOntologyCellularComponent | postsynapse | 1.08e-03 | 1018 | 34 | 7 | GO:0098794 | |
| GeneOntologyCellularComponent | PML body | 1.09e-03 | 125 | 34 | 3 | GO:0016605 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.47e-03 | 523 | 34 | 5 | GO:0098984 | |
| GeneOntologyCellularComponent | actin filament | 1.70e-03 | 146 | 34 | 3 | GO:0005884 | |
| GeneOntologyCellularComponent | neuronal cell body | 2.06e-03 | 835 | 34 | 6 | GO:0043025 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 2.88e-03 | 49 | 34 | 2 | GO:0099092 | |
| GeneOntologyCellularComponent | focal adhesion | 5.07e-03 | 431 | 34 | 4 | GO:0005925 | |
| GeneOntologyCellularComponent | postsynaptic density | 5.94e-03 | 451 | 34 | 4 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 7.22e-03 | 477 | 34 | 4 | GO:0032279 | |
| MousePheno | abnormal somatosensory cortex morphology | 4.15e-09 | 33 | 27 | 5 | MP:0000859 | |
| MousePheno | abnormal parietal lobe morphology | 7.59e-09 | 37 | 27 | 5 | MP:0000794 | |
| MousePheno | abnormal axon pruning | 9.99e-05 | 8 | 27 | 2 | MP:0008960 | |
| MousePheno | abnormal optic tract morphology | 1.60e-04 | 10 | 27 | 2 | MP:0004267 | |
| MousePheno | abnormal barrel cortex morphology | 2.77e-04 | 13 | 27 | 2 | MP:0003989 | |
| MousePheno | abnormal primary somatosensory cortex morphology | 3.22e-04 | 14 | 27 | 2 | MP:0000860 | |
| MousePheno | abnormal learning/memory/conditioning | 3.53e-04 | 1239 | 27 | 9 | MP:0002063 | |
| MousePheno | abnormal cerebral cortex morphology | 3.64e-04 | 328 | 27 | 5 | MP:0000788 | |
| MousePheno | abnormal cognition | 3.68e-04 | 1246 | 27 | 9 | MP:0014114 | |
| Domain | TyrKc | 2.21e-12 | 88 | 33 | 8 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 2.21e-12 | 88 | 33 | 8 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 4.92e-12 | 97 | 33 | 8 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.92e-12 | 97 | 33 | 8 | IPR008266 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 2.48e-11 | 14 | 33 | 5 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 2.48e-11 | 14 | 33 | 5 | PS00790 | |
| Domain | EphA2_TM | 2.48e-11 | 14 | 33 | 5 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 2.48e-11 | 14 | 33 | 5 | IPR016257 | |
| Domain | Eph_TM | 2.48e-11 | 14 | 33 | 5 | IPR027936 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 2.48e-11 | 14 | 33 | 5 | IPR001090 | |
| Domain | Tyr_kinase_rcpt_V_CS | 2.48e-11 | 14 | 33 | 5 | IPR001426 | |
| Domain | EPH_LBD | 2.48e-11 | 14 | 33 | 5 | PS51550 | |
| Domain | EPH_lbd | 2.48e-11 | 14 | 33 | 5 | SM00615 | |
| Domain | Ephrin_lbd | 2.48e-11 | 14 | 33 | 5 | PF01404 | |
| Domain | Pkinase_Tyr | 5.00e-11 | 129 | 33 | 8 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 8.60e-11 | 138 | 33 | 8 | IPR001245 | |
| Domain | Ephrin_rec_like | 6.50e-10 | 25 | 33 | 5 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 6.50e-10 | 25 | 33 | 5 | IPR011641 | |
| Domain | fn3 | 1.15e-08 | 162 | 33 | 7 | PF00041 | |
| Domain | Galactose-bd-like | 1.37e-08 | 94 | 33 | 6 | IPR008979 | |
| Domain | FN3 | 2.87e-08 | 185 | 33 | 7 | SM00060 | |
| Domain | FN3 | 4.74e-08 | 199 | 33 | 7 | PS50853 | |
| Domain | FN3_dom | 6.63e-08 | 209 | 33 | 7 | IPR003961 | |
| Domain | SAM_1 | 1.21e-07 | 68 | 33 | 5 | PF00536 | |
| Domain | - | 1.73e-07 | 73 | 33 | 5 | 2.60.120.260 | |
| Domain | Protein_kinase_ATP_BS | 2.38e-07 | 379 | 33 | 8 | IPR017441 | |
| Domain | Growth_fac_rcpt_ | 2.83e-07 | 156 | 33 | 6 | IPR009030 | |
| Domain | SAM | 4.43e-07 | 88 | 33 | 5 | SM00454 | |
| Domain | SAM_DOMAIN | 6.49e-07 | 95 | 33 | 5 | PS50105 | |
| Domain | SAM | 7.20e-07 | 97 | 33 | 5 | IPR001660 | |
| Domain | PROTEIN_KINASE_ATP | 1.01e-06 | 459 | 33 | 8 | PS00107 | |
| Domain | - | 1.12e-06 | 106 | 33 | 5 | 1.10.150.50 | |
| Domain | Prot_kinase_dom | 1.63e-06 | 489 | 33 | 8 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.73e-06 | 493 | 33 | 8 | PS50011 | |
| Domain | SAM/pointed | 1.83e-06 | 117 | 33 | 5 | IPR013761 | |
| Domain | Kinase-like_dom | 3.50e-06 | 542 | 33 | 8 | IPR011009 | |
| Domain | EGF_2 | 9.49e-05 | 265 | 33 | 5 | PS01186 | |
| Domain | - | 1.31e-04 | 663 | 33 | 7 | 2.60.40.10 | |
| Domain | Ephrin_rec_like | 1.65e-04 | 11 | 33 | 2 | PF07699 | |
| Domain | Ig-like_fold | 1.94e-04 | 706 | 33 | 7 | IPR013783 | |
| Domain | SH2 | 7.44e-04 | 101 | 33 | 3 | PF00017 | |
| Domain | SH2 | 9.54e-04 | 110 | 33 | 3 | SM00252 | |
| Domain | SH2 | 9.79e-04 | 111 | 33 | 3 | PS50001 | |
| Domain | SH2 | 1.00e-03 | 112 | 33 | 3 | IPR000980 | |
| Domain | - | 1.00e-03 | 112 | 33 | 3 | 3.30.505.10 | |
| Domain | EGF-like_CS | 1.11e-03 | 261 | 33 | 4 | IPR013032 | |
| Domain | SH3_1 | 2.99e-03 | 164 | 33 | 3 | PF00018 | |
| Domain | SH3 | 6.45e-03 | 216 | 33 | 3 | PS50002 | |
| Domain | SH3 | 6.45e-03 | 216 | 33 | 3 | SM00326 | |
| Domain | SH3_domain | 6.78e-03 | 220 | 33 | 3 | IPR001452 | |
| Domain | IQ | 6.97e-03 | 71 | 33 | 2 | PF00612 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.01e-15 | 34 | 27 | 8 | MM15025 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 3.48e-14 | 51 | 27 | 8 | M27311 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 6.12e-14 | 92 | 27 | 9 | M27201 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 2.71e-13 | 65 | 27 | 8 | MM14911 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 4.97e-13 | 18 | 27 | 6 | MM15023 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 1.25e-11 | 29 | 27 | 6 | M27309 | |
| Pathway | PID_EPHA_FWDPATHWAY | 3.53e-11 | 34 | 27 | 6 | M177 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.36e-10 | 42 | 27 | 6 | M27308 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 2.40e-09 | 30 | 27 | 5 | M257 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB2 GRIN2B EPHA6 YES1 FYN RPL5 EPHA2 SCN4A SRC EPHA7 EPHB1 | 3.40e-09 | 575 | 27 | 11 | M29853 |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 7.28e-09 | 37 | 27 | 5 | MM15022 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.03e-08 | 261 | 27 | 8 | MM15676 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 3.21e-08 | 18 | 27 | 4 | MM15024 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 4.06e-08 | 19 | 27 | 4 | M27310 | |
| Pathway | WP_NRF2ARE_REGULATION | 9.22e-08 | 23 | 27 | 4 | M39761 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.32e-07 | 129 | 27 | 6 | M5539 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN | 2.18e-07 | 7 | 27 | 3 | M27912 | |
| Pathway | PID_ALPHA_SYNUCLEIN_PATHWAY | 3.70e-07 | 32 | 27 | 4 | M275 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 6.75e-07 | 37 | 27 | 4 | MM14564 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 1.25e-06 | 43 | 27 | 4 | M508 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 1.36e-06 | 12 | 27 | 3 | MM14835 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 1.36e-06 | 12 | 27 | 3 | M11773 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 1.77e-06 | 13 | 27 | 3 | MM14565 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 2.99e-06 | 502 | 27 | 8 | MM14537 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 3.45e-06 | 16 | 27 | 3 | M537 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 6.99e-06 | 20 | 27 | 3 | M39002 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 7.09e-06 | 66 | 27 | 4 | MM15925 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 8.14e-06 | 21 | 27 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 8.14e-06 | 21 | 27 | 3 | MM14996 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 9.50e-06 | 71 | 27 | 4 | MM15947 | |
| Pathway | WP_AXON_GUIDANCE | 1.00e-05 | 72 | 27 | 4 | M48335 | |
| Pathway | REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION | 1.23e-05 | 24 | 27 | 3 | M27803 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK2_TRKB | 1.40e-05 | 25 | 27 | 3 | M27864 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 1.78e-05 | 27 | 27 | 3 | M33 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 2.46e-05 | 30 | 27 | 3 | M76 | |
| Pathway | REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS | 2.72e-05 | 31 | 27 | 3 | M46423 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 2.72e-05 | 31 | 27 | 3 | M27805 | |
| Pathway | PID_NETRIN_PATHWAY | 2.99e-05 | 32 | 27 | 3 | M108 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EPHB2 GRIN2B EPHA6 YES1 FYN RPL5 EPHA2 SCN4A SRC EPHA7 EPHB1 | 3.20e-05 | 1432 | 27 | 11 | M509 |
| Pathway | REACTOME_CD28_CO_STIMULATION | 3.29e-05 | 33 | 27 | 3 | M11725 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 3.60e-05 | 34 | 27 | 3 | MM14992 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 5.91e-05 | 40 | 27 | 3 | M62 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 6.36e-05 | 41 | 27 | 3 | M159 | |
| Pathway | WP_IL11_SIGNALING | 7.88e-05 | 44 | 27 | 3 | M39716 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 7.88e-05 | 44 | 27 | 3 | MM14520 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 9.61e-05 | 47 | 27 | 3 | M39380 | |
| Pathway | BIOCARTA_EPHA4_PATHWAY | 9.82e-05 | 8 | 27 | 2 | M16334 | |
| Pathway | PID_PI3KCI_PATHWAY | 1.02e-04 | 48 | 27 | 3 | M141 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.02e-04 | 48 | 27 | 3 | MM17214 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.16e-04 | 50 | 27 | 3 | M553 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 1.26e-04 | 9 | 27 | 2 | MM15059 | |
| Pathway | BIOCARTA_EPHA4_PATHWAY | 1.26e-04 | 9 | 27 | 2 | MM1388 | |
| Pathway | PID_PTP1B_PATHWAY | 1.30e-04 | 52 | 27 | 3 | M50 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 1.35e-04 | 431 | 27 | 6 | M39729 | |
| Pathway | PID_TXA2PATHWAY | 1.62e-04 | 56 | 27 | 3 | M99 | |
| Pathway | PID_FAK_PATHWAY | 1.90e-04 | 59 | 27 | 3 | M281 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 2.65e-04 | 66 | 27 | 3 | MM14990 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 3.02e-04 | 69 | 27 | 3 | M27108 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 3.17e-04 | 14 | 27 | 2 | M889 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 3.56e-04 | 73 | 27 | 3 | M638 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 3.65e-04 | 15 | 27 | 2 | MM14965 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 3.71e-04 | 74 | 27 | 3 | M17386 | |
| Pathway | PID_SYNDECAN_3_PATHWAY | 4.72e-04 | 17 | 27 | 2 | M251 | |
| Pathway | PID_EPHA2_FWD_PATHWAY | 5.92e-04 | 19 | 27 | 2 | M273 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 6.80e-04 | 91 | 27 | 3 | M39700 | |
| Pathway | PID_ECADHERIN_KERATINOCYTE_PATHWAY | 7.25e-04 | 21 | 27 | 2 | M184 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 7.25e-04 | 21 | 27 | 2 | MM15633 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 7.71e-04 | 95 | 27 | 3 | M29842 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 7.97e-04 | 22 | 27 | 2 | M903 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 8.72e-04 | 23 | 27 | 2 | M39883 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 8.72e-04 | 23 | 27 | 2 | M27949 | |
| Pathway | PID_CXCR4_PATHWAY | 8.95e-04 | 100 | 27 | 3 | M124 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.12e-03 | 26 | 27 | 2 | M39687 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.12e-03 | 26 | 27 | 2 | MM15896 | |
| Pathway | WP_5Q35_COPY_NUMBER_VARIATION | 1.21e-03 | 111 | 27 | 3 | M48089 | |
| Pathway | PID_REELIN_PATHWAY | 1.29e-03 | 28 | 27 | 2 | M69 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.31e-03 | 114 | 27 | 3 | MM14814 | |
| Pathway | WP_GASTRIN_SIGNALING | 1.34e-03 | 115 | 27 | 3 | M39866 | |
| Pathway | REACTOME_PARASITE_INFECTION | 1.37e-03 | 116 | 27 | 3 | M29843 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2 | 1.48e-03 | 119 | 27 | 3 | M27785 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 1.55e-03 | 121 | 27 | 3 | M39804 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.55e-03 | 121 | 27 | 3 | M872 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 1.59e-03 | 31 | 27 | 2 | M213 | |
| Pathway | PID_SYNDECAN_2_PATHWAY | 1.80e-03 | 33 | 27 | 2 | M240 | |
| Pathway | PID_PDGFRB_PATHWAY | 1.86e-03 | 129 | 27 | 3 | M186 | |
| Pathway | PID_ARF6_PATHWAY | 2.02e-03 | 35 | 27 | 2 | M86 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 2.08e-03 | 134 | 27 | 3 | M3574 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 2.08e-03 | 134 | 27 | 3 | M29840 | |
| Pathway | PID_ERBB4_PATHWAY | 2.38e-03 | 38 | 27 | 2 | M13 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 2.50e-03 | 143 | 27 | 3 | M27107 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 2.55e-03 | 144 | 27 | 3 | M39691 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 2.63e-03 | 40 | 27 | 2 | M39798 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 2.63e-03 | 40 | 27 | 2 | M41816 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 2.77e-03 | 41 | 27 | 2 | MM15162 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 3.04e-03 | 43 | 27 | 2 | M39788 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.04e-03 | 532 | 27 | 5 | M27870 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 3.18e-03 | 44 | 27 | 2 | M875 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 3.32e-03 | 158 | 27 | 3 | MM14812 | |
| Pathway | WP_MICROTUBULE_CYTOSKELETON_REGULATION | 3.77e-03 | 48 | 27 | 2 | M39566 | |
| Pathway | PID_AJDISS_2PATHWAY | 3.77e-03 | 48 | 27 | 2 | M142 | |
| Pubmed | 1.28e-14 | 83 | 34 | 8 | 11114734 | ||
| Pubmed | 2.85e-12 | 16 | 34 | 5 | 8755474 | ||
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 4.03e-12 | 17 | 34 | 5 | 12217323 | |
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 7.56e-12 | 19 | 34 | 5 | 12684176 | |
| Pubmed | 1.32e-11 | 21 | 34 | 5 | 9267020 | ||
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 1.32e-11 | 21 | 34 | 5 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 1.32e-11 | 21 | 34 | 5 | 20112066 | |
| Pubmed | 1.32e-11 | 21 | 34 | 5 | 11128993 | ||
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 1.32e-11 | 21 | 34 | 5 | 10730216 | |
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 2.18e-11 | 23 | 34 | 5 | 19542359 | |
| Pubmed | 2.66e-11 | 7 | 34 | 4 | 9632142 | ||
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 2.75e-11 | 24 | 34 | 5 | 16446123 | |
| Pubmed | 9.55e-11 | 9 | 34 | 4 | 11403717 | ||
| Pubmed | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. | 1.59e-10 | 10 | 34 | 4 | 17304517 | |
| Pubmed | SRC family kinases are required for limb trajectory selection by spinal motor axons. | 2.50e-10 | 11 | 34 | 4 | 19403835 | |
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 3.75e-10 | 12 | 34 | 4 | 21465626 | |
| Pubmed | 7.56e-10 | 14 | 34 | 4 | 26941654 | ||
| Pubmed | Src family kinases are required for integrin but not PDGFR signal transduction. | 8.54e-10 | 3 | 34 | 3 | 10228160 | |
| Pubmed | Localized activation of Src-family protein kinases in the mouse egg. | 8.54e-10 | 3 | 34 | 3 | 17449027 | |
| Pubmed | Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. | 8.54e-10 | 3 | 34 | 3 | 7958873 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 23497302 | ||
| Pubmed | Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events. | 8.54e-10 | 3 | 34 | 3 | 16400523 | |
| Pubmed | Requirement of SRC-family tyrosine kinases in fat accumulation. | 8.54e-10 | 3 | 34 | 3 | 16262245 | |
| Pubmed | Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake. | 8.54e-10 | 3 | 34 | 3 | 20080640 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 20176789 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 11483655 | ||
| Pubmed | Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. | 8.54e-10 | 3 | 34 | 3 | 10635317 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 11024032 | ||
| Pubmed | 1.49e-09 | 51 | 34 | 5 | 19769959 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 7681396 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 10458595 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 11245687 | ||
| Pubmed | Autophosphorylation activity and association with Src family kinase of Sky receptor tyrosine kinase. | 3.41e-09 | 4 | 34 | 3 | 7537495 | |
| Pubmed | Endocytosis of collagen by hepatic stellate cells regulates extracellular matrix dynamics. | 3.41e-09 | 4 | 34 | 3 | 25080486 | |
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 19258394 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 16585062 | ||
| Pubmed | Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation. | 3.41e-09 | 4 | 34 | 3 | 25157176 | |
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 7521304 | ||
| Pubmed | State and role of SRC family kinases in replication of herpes simplex virus 1. | 3.41e-09 | 4 | 34 | 3 | 16537602 | |
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 14559149 | ||
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 3.65e-09 | 20 | 34 | 4 | 11256076 | |
| Pubmed | 3.65e-09 | 20 | 34 | 4 | 9530499 | ||
| Pubmed | 3.65e-09 | 20 | 34 | 4 | 10207129 | ||
| Pubmed | 3.65e-09 | 20 | 34 | 4 | 9576626 | ||
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 6.65e-09 | 23 | 34 | 4 | 25480914 | |
| Pubmed | Palatal adhesion is dependent on Src family kinases and p38MAPK. | 8.52e-09 | 5 | 34 | 3 | 25354453 | |
| Pubmed | Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases. | 8.52e-09 | 5 | 34 | 3 | 12846735 | |
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 12084815 | ||
| Pubmed | Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. | 8.52e-09 | 5 | 34 | 3 | 18194650 | |
| Pubmed | Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells. | 8.52e-09 | 5 | 34 | 3 | 22971575 | |
| Pubmed | Eph receptors are involved in the activity-dependent synaptic wiring in the mouse cerebellar cortex. | 8.52e-09 | 5 | 34 | 3 | 21559471 | |
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 18255094 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 17623777 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 12509223 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 11448999 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 10844001 | ||
| Pubmed | 1.32e-08 | 78 | 34 | 5 | 17192257 | ||
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 19420001 | ||
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 20606012 | ||
| Pubmed | Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. | 1.70e-08 | 6 | 34 | 3 | 10861086 | |
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 12923167 | ||
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 9799234 | ||
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 16723512 | ||
| Pubmed | Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. | 1.70e-08 | 6 | 34 | 3 | 2404338 | |
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 1381360 | ||
| Pubmed | Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. | 2.98e-08 | 7 | 34 | 3 | 12526739 | |
| Pubmed | 2.98e-08 | 7 | 34 | 3 | 12538589 | ||
| Pubmed | CMS: an adapter molecule involved in cytoskeletal rearrangements. | 2.98e-08 | 7 | 34 | 3 | 10339567 | |
| Pubmed | Specific interactions of neuronal focal adhesion kinase isoforms with Src kinases and amphiphysin. | 2.98e-08 | 7 | 34 | 3 | 12558988 | |
| Pubmed | The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. | 2.98e-08 | 7 | 34 | 3 | 10829062 | |
| Pubmed | QM, a putative tumor suppressor, regulates proto-oncogene c-yes. | 2.98e-08 | 7 | 34 | 3 | 12138090 | |
| Pubmed | NMDA-receptor proteins are upregulated in the hippocampus of postnatal heterozygous reeler mice. | 2.98e-08 | 7 | 34 | 3 | 16438943 | |
| Pubmed | 2.98e-08 | 7 | 34 | 3 | 10858437 | ||
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 3.05e-08 | 33 | 34 | 4 | 26830346 | |
| Pubmed | 4.76e-08 | 8 | 34 | 3 | 12640114 | ||
| Pubmed | 4.76e-08 | 8 | 34 | 3 | 15190072 | ||
| Pubmed | Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2. | 4.76e-08 | 8 | 34 | 3 | 14988728 | |
| Pubmed | 4.76e-08 | 8 | 34 | 3 | 21829547 | ||
| Pubmed | Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis. | 4.76e-08 | 8 | 34 | 3 | 16921024 | |
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 9892651 | ||
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 18713744 | ||
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 15716419 | ||
| Pubmed | Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit. | 7.14e-08 | 9 | 34 | 3 | 18697750 | |
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 8.30e-08 | 42 | 34 | 4 | 11439183 | |
| Pubmed | 1.02e-07 | 10 | 34 | 3 | 25073978 | ||
| Pubmed | 1.02e-07 | 10 | 34 | 3 | 16687575 | ||
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 1.02e-07 | 10 | 34 | 3 | 16547242 | |
| Pubmed | 1.40e-07 | 11 | 34 | 3 | 22065784 | ||
| Pubmed | 1.40e-07 | 11 | 34 | 3 | 11312300 | ||
| Pubmed | 1.40e-07 | 11 | 34 | 3 | 18499741 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.61e-07 | 910 | 34 | 9 | 36736316 | |
| Pubmed | 2.42e-07 | 13 | 34 | 3 | 16162939 | ||
| Pubmed | Eph-ephrin A system regulates murine blastocyst attachment and spreading. | 2.42e-07 | 13 | 34 | 3 | 17039519 | |
| Pubmed | 2.42e-07 | 13 | 34 | 3 | 12528186 | ||
| Pubmed | A role for the EphA family in the topographic targeting of vomeronasal axons. | 3.08e-07 | 14 | 34 | 3 | 11222144 | |
| Pubmed | The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome. | 3.08e-07 | 14 | 34 | 3 | 29568343 | |
| Pubmed | 3.85e-07 | 15 | 34 | 3 | 25036101 | ||
| Pubmed | Integrin signalling regulates YAP and TAZ to control skin homeostasis. | 3.85e-07 | 15 | 34 | 3 | 26989177 | |
| Pubmed | 4.74e-07 | 16 | 34 | 3 | 38429579 | ||
| Pubmed | 8.18e-07 | 19 | 34 | 3 | 23616926 | ||
| Interaction | EFNA5 interactions | 1.21e-09 | 68 | 33 | 6 | int:EFNA5 | |
| Interaction | EPHB2 interactions | 1.69e-09 | 216 | 33 | 8 | int:EPHB2 | |
| Interaction | CSF1R interactions | 2.22e-09 | 75 | 33 | 6 | int:CSF1R | |
| Interaction | CTNNB1 interactions | EPHB2 ASPM GRIN2B PTPRU SIPA1L2 FYN AR EPHA2 PARK7 MAEA SRC EPHA7 | 3.11e-08 | 1009 | 33 | 12 | int:CTNNB1 |
| Interaction | ARHGAP32 interactions | 1.39e-07 | 149 | 33 | 6 | int:ARHGAP32 | |
| Interaction | PIK3R1 interactions | 2.53e-07 | 412 | 33 | 8 | int:PIK3R1 | |
| Interaction | PTK2 interactions | 6.43e-07 | 315 | 33 | 7 | int:PTK2 | |
| Interaction | CDC37 interactions | 6.46e-07 | 645 | 33 | 9 | int:CDC37 | |
| Interaction | EFNA1 interactions | 6.70e-07 | 103 | 33 | 5 | int:EFNA1 | |
| Interaction | LRRIQ1 interactions | 7.03e-07 | 43 | 33 | 4 | int:LRRIQ1 | |
| Interaction | PIK3R3 interactions | 7.40e-07 | 198 | 33 | 6 | int:PIK3R3 | |
| Interaction | EPHA6 interactions | 8.46e-07 | 45 | 33 | 4 | int:EPHA6 | |
| Interaction | AFDN interactions | 9.32e-07 | 333 | 33 | 7 | int:AFDN | |
| Interaction | EPHA3 interactions | 9.72e-07 | 111 | 33 | 5 | int:EPHA3 | |
| Interaction | SPR interactions | 1.06e-06 | 113 | 33 | 5 | int:SPR | |
| Interaction | ACBD7 interactions | 1.44e-06 | 14 | 33 | 3 | int:ACBD7 | |
| Interaction | GRM1 interactions | 3.11e-06 | 62 | 33 | 4 | int:GRM1 | |
| Interaction | CTNND1 interactions | 4.02e-06 | 265 | 33 | 6 | int:CTNND1 | |
| Interaction | MALL interactions | 4.29e-06 | 150 | 33 | 5 | int:MALL | |
| Interaction | PTPRE interactions | 4.78e-06 | 69 | 33 | 4 | int:PTPRE | |
| Interaction | TRPV4 interactions | 6.03e-06 | 22 | 33 | 3 | int:TRPV4 | |
| Interaction | DCC interactions | 6.32e-06 | 74 | 33 | 4 | int:DCC | |
| Interaction | CBLC interactions | 6.67e-06 | 75 | 33 | 4 | int:CBLC | |
| Interaction | RASA1 interactions | 7.24e-06 | 167 | 33 | 5 | int:RASA1 | |
| Interaction | SDC1 interactions | 8.63e-06 | 80 | 33 | 4 | int:SDC1 | |
| Interaction | CYFIP1 interactions | 8.65e-06 | 303 | 33 | 6 | int:CYFIP1 | |
| Interaction | SHB interactions | 1.05e-05 | 84 | 33 | 4 | int:SHB | |
| Interaction | TMEM185A interactions | 1.20e-05 | 87 | 33 | 4 | int:TMEM185A | |
| Interaction | EPHA4 interactions | 1.29e-05 | 188 | 33 | 5 | int:EPHA4 | |
| Interaction | SLC25A41 interactions | 1.38e-05 | 90 | 33 | 4 | int:SLC25A41 | |
| Interaction | PXN interactions | 1.50e-05 | 334 | 33 | 6 | int:PXN | |
| Interaction | NPHS1 interactions | 1.58e-05 | 30 | 33 | 3 | int:NPHS1 | |
| Interaction | CAV1 interactions | 1.67e-05 | 724 | 33 | 8 | int:CAV1 | |
| Interaction | KALRN interactions | 1.78e-05 | 96 | 33 | 4 | int:KALRN | |
| Interaction | PRUNE2 interactions | 1.92e-05 | 32 | 33 | 3 | int:PRUNE2 | |
| Interaction | PECAM1 interactions | 1.92e-05 | 32 | 33 | 3 | int:PECAM1 | |
| Interaction | CASP8 interactions | 2.40e-05 | 214 | 33 | 5 | int:CASP8 | |
| Interaction | ACP1 interactions | 2.44e-05 | 104 | 33 | 4 | int:ACP1 | |
| Interaction | PTPN11 interactions | 2.60e-05 | 368 | 33 | 6 | int:PTPN11 | |
| Interaction | ABL2 interactions | 2.73e-05 | 107 | 33 | 4 | int:ABL2 | |
| Interaction | SEC23B interactions | 2.86e-05 | 222 | 33 | 5 | int:SEC23B | |
| Interaction | YES1 interactions | 2.89e-05 | 375 | 33 | 6 | int:YES1 | |
| Interaction | CDH5 interactions | 2.94e-05 | 109 | 33 | 4 | int:CDH5 | |
| Interaction | EFS interactions | 2.99e-05 | 37 | 33 | 3 | int:EFS | |
| Interaction | PDGFRB interactions | 3.25e-05 | 228 | 33 | 5 | int:PDGFRB | |
| Interaction | PIK3R2 interactions | 3.39e-05 | 230 | 33 | 5 | int:PIK3R2 | |
| Interaction | CD36 interactions | 3.51e-05 | 39 | 33 | 3 | int:CD36 | |
| Interaction | GRB2 interactions | 3.60e-05 | 806 | 33 | 8 | int:GRB2 | |
| Interaction | CD44 interactions | 4.07e-05 | 239 | 33 | 5 | int:CD44 | |
| Interaction | LIN7C interactions | 4.14e-05 | 119 | 33 | 4 | int:LIN7C | |
| Interaction | KIT interactions | 5.02e-05 | 125 | 33 | 4 | int:KIT | |
| Interaction | CALM1 interactions | 5.70e-05 | 626 | 33 | 7 | int:CALM1 | |
| Interaction | RANBP9 interactions | 6.43e-05 | 433 | 33 | 6 | int:RANBP9 | |
| Interaction | PLCG1 interactions | 6.53e-05 | 264 | 33 | 5 | int:PLCG1 | |
| Interaction | EPS8 interactions | 6.97e-05 | 136 | 33 | 4 | int:EPS8 | |
| Interaction | EFCAB6 interactions | 7.24e-05 | 8 | 33 | 2 | int:EFCAB6 | |
| Interaction | SKAP2 interactions | 7.90e-05 | 51 | 33 | 3 | int:SKAP2 | |
| Interaction | IL7R interactions | 8.02e-05 | 141 | 33 | 4 | int:IL7R | |
| Interaction | PEBP1 interactions | 8.19e-05 | 277 | 33 | 5 | int:PEBP1 | |
| Interaction | SRC interactions | 8.26e-05 | 664 | 33 | 7 | int:SRC | |
| Interaction | EFNB2 interactions | 8.48e-05 | 143 | 33 | 4 | int:EFNB2 | |
| Interaction | SDC2 interactions | 8.48e-05 | 143 | 33 | 4 | int:SDC2 | |
| Interaction | LCK interactions | 9.31e-05 | 463 | 33 | 6 | int:LCK | |
| Interaction | FLOT2 interactions | 9.37e-05 | 285 | 33 | 5 | int:FLOT2 | |
| Interaction | PCDHGC3 interactions | 9.37e-05 | 54 | 33 | 3 | int:PCDHGC3 | |
| Interaction | PTEN interactions | 9.81e-05 | 929 | 33 | 8 | int:PTEN | |
| Interaction | PDIA4 interactions | 9.88e-05 | 468 | 33 | 6 | int:PDIA4 | |
| Interaction | SH3BP1 interactions | 9.90e-05 | 55 | 33 | 3 | int:SH3BP1 | |
| Interaction | GJB7 interactions | 1.05e-04 | 56 | 33 | 3 | int:GJB7 | |
| Interaction | HNRNPA1L2 interactions | 1.05e-04 | 151 | 33 | 4 | int:HNRNPA1L2 | |
| Interaction | FLOT1 interactions | 1.07e-04 | 475 | 33 | 6 | int:FLOT1 | |
| Interaction | GRIN1 interactions | 1.13e-04 | 154 | 33 | 4 | int:GRIN1 | |
| Interaction | CEP15 interactions | 1.16e-04 | 10 | 33 | 2 | int:CEP15 | |
| Interaction | IGSF9B interactions | 1.16e-04 | 10 | 33 | 2 | int:IGSF9B | |
| Interaction | RACK1 interactions | 1.19e-04 | 704 | 33 | 7 | int:RACK1 | |
| Interaction | JUP interactions | 1.20e-04 | 485 | 33 | 6 | int:JUP | |
| Interaction | DOK1 interactions | 1.22e-04 | 59 | 33 | 3 | int:DOK1 | |
| Interaction | MED21 interactions | 1.28e-04 | 159 | 33 | 4 | int:MED21 | |
| Interaction | NISCH interactions | 1.31e-04 | 160 | 33 | 4 | int:NISCH | |
| Interaction | TYRO3 interactions | 1.31e-04 | 160 | 33 | 4 | int:TYRO3 | |
| Interaction | GRB10 interactions | 1.34e-04 | 161 | 33 | 4 | int:GRB10 | |
| Interaction | EPHA2 interactions | 1.36e-04 | 719 | 33 | 7 | int:EPHA2 | |
| Interaction | TUBA1B interactions | 1.39e-04 | 498 | 33 | 6 | int:TUBA1B | |
| Interaction | ZDHHC6 interactions | 1.42e-04 | 62 | 33 | 3 | int:ZDHHC6 | |
| Interaction | GAB3 interactions | 1.42e-04 | 11 | 33 | 2 | int:GAB3 | |
| Interaction | OCLN interactions | 1.42e-04 | 500 | 33 | 6 | int:OCLN | |
| Interaction | SNTB1 interactions | 1.49e-04 | 63 | 33 | 3 | int:SNTB1 | |
| Interaction | PIM3 interactions | 1.49e-04 | 63 | 33 | 3 | int:PIM3 | |
| Interaction | ANAPC16 interactions | 1.63e-04 | 65 | 33 | 3 | int:ANAPC16 | |
| Interaction | GRIN2B interactions | 1.65e-04 | 170 | 33 | 4 | int:GRIN2B | |
| Interaction | CBL interactions | 1.68e-04 | 516 | 33 | 6 | int:CBL | |
| Interaction | CYFIP2 interactions | 1.68e-04 | 323 | 33 | 5 | int:CYFIP2 | |
| Interaction | NSUN2 interactions | 1.68e-04 | 323 | 33 | 5 | int:NSUN2 | |
| Interaction | PAG1 interactions | 1.78e-04 | 67 | 33 | 3 | int:PAG1 | |
| Interaction | ADAM15 interactions | 1.95e-04 | 69 | 33 | 3 | int:ADAM15 | |
| Interaction | GAB1 interactions | 1.97e-04 | 178 | 33 | 4 | int:GAB1 | |
| Interaction | GDF15 interactions | 2.03e-04 | 70 | 33 | 3 | int:GDF15 | |
| Interaction | AIP interactions | 2.15e-04 | 182 | 33 | 4 | int:AIP | |
| Interaction | NHERF1 interactions | 2.19e-04 | 183 | 33 | 4 | int:NHERF1 | |
| Interaction | SHC3 interactions | 2.21e-04 | 72 | 33 | 3 | int:SHC3 | |
| Cytoband | 1p35.3 | 2.94e-04 | 34 | 34 | 2 | 1p35.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p35 | 4.66e-03 | 137 | 34 | 2 | chr1p35 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 5.25e-12 | 14 | 24 | 5 | 1095 | |
| GeneFamily | Fibronectin type III domain containing | 1.14e-09 | 160 | 24 | 7 | 555 | |
| GeneFamily | Sterile alpha motif domain containing | 9.62e-08 | 88 | 24 | 5 | 760 | |
| GeneFamily | SH2 domain containing | 3.14e-04 | 101 | 24 | 3 | 741 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.46e-05 | 196 | 34 | 4 | 8faac7fbdee3a9297023c3151ef1751605413e44 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-05 | 198 | 34 | 4 | 039b67ddd0ac529453a364552abca04e67d8417c | |
| ToppCell | mLN-(5)_Dendritic_cell-(54)_pDC|mLN / shred on region, Cell_type, and subtype | 1.55e-05 | 199 | 34 | 4 | 1e738219784a446ee8b0ddeb408e0050e1929e60 | |
| ToppCell | mLN-Dendritic_cell-pDC|mLN / Region, Cell class and subclass | 1.55e-05 | 199 | 34 | 4 | 54f1abb57af7bf8a8b82a38b933f257df3b5d8df | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.68e-04 | 141 | 34 | 3 | 2d2c468783730d81e3cacb0336027ba0ce1e5f4f | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 145 | 34 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.18e-04 | 154 | 34 | 3 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.44e-04 | 160 | 34 | 3 | 9049707a4487f2337a17976ceb5fbd8815ab9e1d | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.44e-04 | 160 | 34 | 3 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.44e-04 | 160 | 34 | 3 | f2cfec54cf48a655f473b830be7d141c54b521ff | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.44e-04 | 160 | 34 | 3 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.44e-04 | 160 | 34 | 3 | 0eb50b3c494e1b65d40104b3b5411b57bb72b959 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 160 | 34 | 3 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-04 | 162 | 34 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-04 | 166 | 34 | 3 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-04 | 166 | 34 | 3 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 166 | 34 | 3 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.81e-04 | 168 | 34 | 3 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 2.81e-04 | 168 | 34 | 3 | cfed36fece51871a5abbcde71f6bd5e7212357ff | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.86e-04 | 169 | 34 | 3 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 170 | 34 | 3 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 170 | 34 | 3 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 170 | 34 | 3 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 171 | 34 | 3 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 2.96e-04 | 171 | 34 | 3 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 3.01e-04 | 172 | 34 | 3 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 172 | 34 | 3 | 3f894c74916d49a995b2d4651ca1c6733c14ce9c | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 3.01e-04 | 172 | 34 | 3 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 3.01e-04 | 172 | 34 | 3 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.01e-04 | 172 | 34 | 3 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 34 | 3 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 34 | 3 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 3.11e-04 | 174 | 34 | 3 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.17e-04 | 175 | 34 | 3 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 175 | 34 | 3 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 3.17e-04 | 175 | 34 | 3 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 176 | 34 | 3 | d4075796c38b775fe721abb47426e662a0d415e3 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 3.22e-04 | 176 | 34 | 3 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.22e-04 | 176 | 34 | 3 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.22e-04 | 176 | 34 | 3 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 3.22e-04 | 176 | 34 | 3 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|myeloid / Lineage, cell class and subclass | 3.33e-04 | 178 | 34 | 3 | f75591988bbbeba073b66329a3437cb9b02f7648 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 3.33e-04 | 178 | 34 | 3 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-04 | 179 | 34 | 3 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.38e-04 | 179 | 34 | 3 | 124da6f882968dc0d05f3edd8f3b4d61617cc214 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.38e-04 | 179 | 34 | 3 | c815eb9f760fe4ca7a5e49beb224659f0b864f22 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.38e-04 | 179 | 34 | 3 | edc5ef693dc4e7ea70717b77fb908fc784dce3a2 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-04 | 179 | 34 | 3 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-04 | 179 | 34 | 3 | 1757b9f3f4c634277a67c4f5a39d27d6b4937073 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 3.38e-04 | 179 | 34 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-04 | 180 | 34 | 3 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-04 | 180 | 34 | 3 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-04 | 180 | 34 | 3 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-04 | 180 | 34 | 3 | df60970520fba2ac0639faa54096766d07418ca4 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.44e-04 | 180 | 34 | 3 | 9adebde5f4ca6dcb90e9113622862e14298465ac | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-04 | 180 | 34 | 3 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 3.50e-04 | 181 | 34 | 3 | 66d890a105f955dca91d6e5e6c730d1a68ee9233 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.50e-04 | 181 | 34 | 3 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 181 | 34 | 3 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 181 | 34 | 3 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 181 | 34 | 3 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-04 | 182 | 34 | 3 | f703963b5d1e8c1f95d78807521048553b0792d8 | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 3.55e-04 | 182 | 34 | 3 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-04 | 182 | 34 | 3 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-04 | 182 | 34 | 3 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.55e-04 | 182 | 34 | 3 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-tDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.55e-04 | 182 | 34 | 3 | ad5c99ec62cdab347d3a03c971d981e3b924020c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.55e-04 | 182 | 34 | 3 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-04 | 182 | 34 | 3 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.55e-04 | 182 | 34 | 3 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.55e-04 | 182 | 34 | 3 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-04 | 182 | 34 | 3 | ebd177ad5eac51bf2db0657596618bdf1e5d46e1 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 3.61e-04 | 183 | 34 | 3 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.73e-04 | 185 | 34 | 3 | cc5152d3055375172bdf84f442b233c8fbd422b3 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 185 | 34 | 3 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 3.73e-04 | 185 | 34 | 3 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 185 | 34 | 3 | 01bbe1e09f9ccae837a03ea2cdd168fa10800942 | |
| ToppCell | Bac-SEP-Myeloid-pDC|Bac-SEP / Disease, Lineage and Cell Type | 3.73e-04 | 185 | 34 | 3 | 3de50b2042f22b0fb62ff12c76d85cc67649a0bd | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.79e-04 | 186 | 34 | 3 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.79e-04 | 186 | 34 | 3 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-04 | 186 | 34 | 3 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.79e-04 | 186 | 34 | 3 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.85e-04 | 187 | 34 | 3 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | IIH-pDC-|IIH / Condition, Cell_class and T cell subcluster | 3.85e-04 | 187 | 34 | 3 | ad87b146ea8dd9f695e722f8f0e8e1057c7f3167 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 3.85e-04 | 187 | 34 | 3 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | LAM-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 3.85e-04 | 187 | 34 | 3 | 4d9ffd2bbdf1c9869e28991ce9331e4ccf3c0166 | |
| ToppCell | IIH-pDC|IIH / Condition, Cell_class and T cell subcluster | 3.85e-04 | 187 | 34 | 3 | 5e59e9153a18bcfb5c8dc94599080216661de7ce | |
| ToppCell | control-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.85e-04 | 187 | 34 | 3 | c78aee98b32719aa45811b620fc97be1ecf5fd53 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | e54e09d34e263d5709c337914809e61e74e20591 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-04 | 188 | 34 | 3 | e35104ca327c2d9eb6ffed658051f62f855a0a0e | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | 7fc9810ab14354cb512e2b1285562009c10203f5 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.91e-04 | 188 | 34 | 3 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | myeloid-pDC|myeloid / Lineage and Cell class | 3.91e-04 | 188 | 34 | 3 | a2dc4bbeca2bdc00c51825dd65a699c54c72f241 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 3.97e-04 | 189 | 34 | 3 | 6c2ace61a7d62bcf7e76b73e2da8b722d03e713b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 189 | 34 | 3 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group, lineage and cell class | 3.97e-04 | 189 | 34 | 3 | 46770b99da42f11f10cfc67cea8562342d60b867 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 190 | 34 | 3 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 4.03e-04 | 190 | 34 | 3 | dde0e34f6a06cdbbb65c86472360c09f0279a572 | |
| ToppCell | PBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.03e-04 | 190 | 34 | 3 | adffa93635da10251f28b2089fd96b189775c8b4 | |
| ToppCell | BLOOD--(3)_MNP-(3)_DC_(cDC+pDC)|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.03e-04 | 190 | 34 | 3 | 9b8de47f7a2e6137d934ccce32417ab15eb54f46 | |
| Computational | Genes in the cancer module 80. | 3.74e-07 | 32 | 21 | 4 | MODULE_80 | |
| Computational | Genes in the cancer module 51. | 6.09e-07 | 36 | 21 | 4 | MODULE_51 | |
| Computational | Genes in the cancer module 85. | 2.53e-06 | 51 | 21 | 4 | MODULE_85 | |
| Computational | Genes in the cancer module 199. | 3.98e-06 | 57 | 21 | 4 | MODULE_199 | |
| Computational | Genes in the cancer module 200. | 1.82e-05 | 27 | 21 | 3 | MODULE_200 | |
| Computational | Porins / transporters. | 4.38e-05 | 211 | 21 | 5 | MODULE_63 | |
| Computational | RTK signaling. | 9.24e-05 | 46 | 21 | 3 | MODULE_259 | |
| Computational | Genes in the cancer module 27. | 5.02e-04 | 355 | 21 | 5 | MODULE_27 | |
| Drug | ponatinib | 6.20e-12 | 68 | 33 | 7 | ctd:C545373 | |
| Drug | vandetanib | 9.23e-11 | 99 | 33 | 7 | CID003081361 | |
| Drug | Dasatinib | 7.63e-10 | 10 | 33 | 4 | DB01254 | |
| Drug | sunitinib | 3.01e-08 | 130 | 33 | 6 | CID005329102 | |
| Drug | BIRB796 | 3.91e-08 | 66 | 33 | 5 | CID000156422 | |
| Drug | VX-745 | 4.53e-08 | 25 | 33 | 4 | CID003038525 | |
| Drug | EKB-569 | 1.58e-07 | 87 | 33 | 5 | CID006445562 | |
| Drug | N-(2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)ethyl)glycyrrhetinamide | 6.05e-07 | 12 | 33 | 3 | ctd:C568507 | |
| Drug | imatinib | 2.28e-06 | 430 | 33 | 7 | CID000005291 | |
| Drug | dasatinib | 3.13e-06 | 70 | 33 | 4 | CID003062316 | |
| Drug | SKF 10,047 | 7.92e-06 | 27 | 33 | 3 | CID000001235 | |
| Drug | Pindolol [13523-86-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 8.98e-06 | 197 | 33 | 5 | 2075_UP | |
| Drug | 1-methyl-1H-indole-2-carboxylic acid | 1.22e-05 | 4 | 33 | 2 | CID000027695 | |
| Drug | IN1076 | 2.03e-05 | 112 | 33 | 4 | CID000005309 | |
| Drug | Naphthols | 3.04e-05 | 6 | 33 | 2 | ctd:D009284 | |
| Drug | 3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole | 3.04e-05 | 6 | 33 | 2 | ctd:C104750 | |
| Drug | G 3012 | 3.88e-05 | 132 | 33 | 4 | CID000120739 | |
| Drug | NSC618487 | 4.30e-05 | 933 | 33 | 8 | CID000005279 | |
| Drug | NSC624746 | 7.70e-05 | 57 | 33 | 3 | CID000107640 | |
| Drug | sorafenib | 7.81e-05 | 158 | 33 | 4 | CID000216239 | |
| Drug | nsc25485 | 8.11e-05 | 312 | 33 | 5 | CID000004605 | |
| Drug | Celtol | 9.90e-05 | 62 | 33 | 3 | CID000031726 | |
| Drug | epoxiconazole | 1.23e-04 | 341 | 33 | 5 | ctd:C109476 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.29e-04 | 180 | 33 | 4 | 4821_DN | |
| Drug | estromustine | 1.33e-04 | 12 | 33 | 2 | CID000124946 | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 1.53e-04 | 188 | 33 | 4 | 6186_DN | |
| Drug | ammonium acetate | 1.57e-04 | 13 | 33 | 2 | ctd:C018824 | |
| Drug | Aconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 1.76e-04 | 195 | 33 | 4 | 2776_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.83e-04 | 197 | 33 | 4 | 6930_DN | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 1.83e-04 | 197 | 33 | 4 | 2306_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 2106_UP | |
| Drug | DNA-PK Inhibitor III; Up 200; 1uM; MCF7; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 7513_UP | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 6214_DN | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 2322_DN | |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.94e-04 | 200 | 33 | 4 | 5831_DN | |
| Drug | PD173952 | 2.11e-04 | 15 | 33 | 2 | CID005328733 | |
| Drug | PD173956 | 2.11e-04 | 15 | 33 | 2 | CID005330524 | |
| Drug | QX-314 | 2.27e-04 | 82 | 33 | 3 | CID000003925 | |
| Disease | colorectal cancer (implicated_via_orthology) | 5.07e-06 | 30 | 33 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 6.18e-06 | 32 | 33 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | kidney disease (implicated_via_orthology) | 1.32e-05 | 41 | 33 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | carcinoma (implicated_via_orthology) | 5.07e-05 | 64 | 33 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of prostate | 2.28e-04 | 20 | 33 | 2 | C0007112 | |
| Disease | prostate cancer (is_implicated_in) | 3.04e-04 | 117 | 33 | 3 | DOID:10283 (is_implicated_in) | |
| Disease | Parkinsonism (implicated_via_orthology) | 4.83e-04 | 29 | 33 | 2 | DOID:0080855 (implicated_via_orthology) | |
| Disease | stomach cancer (is_marker_for) | 5.36e-04 | 142 | 33 | 3 | DOID:10534 (is_marker_for) | |
| Disease | Squamous cell carcinoma of lung | 5.89e-04 | 32 | 33 | 2 | C0149782 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRSEQLMDYHRNMGY | 456 | Q9P2B7 | |
| YYTFANMAMLNHLRR | 661 | Q01433 | |
| SAYRGMQARKMYIHI | 1641 | Q8IZT6 | |
| GMKYLAEMNYVHRDL | 731 | P54762 | |
| DRMMVEHLLRCGYYN | 126 | Q7L5Y9 | |
| LRKMMDSGQIDFYQH | 156 | Q9Y692 | |
| DVRYHQQYQKEMRGM | 261 | Q86VF7 | |
| AAGMKYLADMNYVHR | 731 | P29323 | |
| NCRNKDHYGIMMYHR | 306 | Q14149 | |
| DKMMNGGHYTYSENR | 131 | Q99497 | |
| FNEYRMHKSRMYSQC | 771 | P10275 | |
| MRYLADMGYVHRDLA | 746 | Q15375 | |
| RNYKPNMVETMDQYH | 1416 | Q92729 | |
| GMKYLANMNYVHRDL | 726 | P29317 | |
| AGMAYIERMNYIHRD | 376 | P06241 | |
| VKSNRMHAVNGYMYG | 616 | Q6MZM0 | |
| SYLESFYHMMDRRNI | 701 | Q6P179 | |
| SKHYDQYMERMRDEK | 471 | Q86UP8 | |
| MKYLSDMGYVHRDLA | 786 | Q9UF33 | |
| GMAYVERMNYVHRDL | 376 | P12931 | |
| HLLQRSMKQASYMYR | 1741 | P35499 | |
| QGGKMAYYEMRAEHS | 231 | Q8NFW8 | |
| MMHRTGLYNYYDDEK | 236 | P50454 | |
| MLRGYRVENYDHKAM | 211 | Q9P2F8 | |
| RKHIMGQNVADYMRY | 196 | P46777 | |
| YMVENHGEDYKAMAR | 121 | Q9Y3C1 | |
| MHYGNIMYDRRVIRG | 186 | Q86UC2 | |
| RKKMVRNDMFYNHYP | 2381 | Q8IZQ1 | |
| RKYKMNMYGLHDGQR | 1536 | P22105 | |
| MNHEYMYRYRQDPGK | 46 | A0A0A0MS04 | |
| RHYYLQGMIDSKVML | 116 | Q9H8Y1 | |
| RHLYKDVMLENYGNM | 86 | Q5JNZ3 | |
| ADGMAYIERMNYIHR | 381 | P07947 | |
| RNNYAEMHAYMGKFN | 696 | Q13224 |